In gynaecologic practice many peri- and postmenopausal women present to the physician
with new complaints of changes in sexual desire or pain with intercourse that affects
their relationships and quality of life.
1.
,
2.
Postmenopausal women are interested in sex for physical pleasure, intimacy, and expression
of love, as well as to please their partner.
3
Maintenance of sexuality is important for the well-being of women as they navigate
the emotional and physical challenges of menopause.
2.
,
4.
The most commonly reported sexual problems in mid-life women are loss of libido and
dyspareunia.
2.
,
5.
,
10.
Although 52% of naturally menopausal women versus 27% of premenopausal women report
low sexual desire,
5
only 10% to 15% of women are distressed by their sexual problems.
8
As well, up to 50% of women report vaginal discomfort within 3 years of menopause.
11
To read this article in full you will need to make a payment
Subscribe to Journal of Obstetrics and Gynaecology Canada
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Hypoactive sexual desire disorder in postmenopausal women. US results from the Women’s International Study of Health on Sexuality (WISHeS).Menopause. 2006; 13: 46-56
- The relationship between self-reported sexual satisfaction and general well-being in women.J Sex Med. 2009; 6: 2690-2697
- Female sexual health consensus clinical guidelines.J Obstet Gynaecol Can. 2012; 34: S1-S60
- Sexual concerns — menopause and sexual function.in: Bélisle S. Blake J. SOGC Menopause Guidelines Committee Canadian Consensus Conference on Menopause, 2006 update. SOGC Clinical Practice Guidelines, No. 171, February 2006. J Obstet Gynaecol Can. 28. 2006: S43-S52
- Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.Arch Intern Med. 2008; 168: 1441-1449
- Longitudinal changes in sexual functioning as women transition through menopause; results from the study of Women’s Health Across the Nation.Menopause. 2009; 16: 442-452
- A study of sexuality and health among older adults in the United States.N Engl J Med. 2007; 357: 762-774
- Sexual problems and distress in United States women: prevalence and correlates.Obstet Gynecol. 2008; 112: 970-978
- Increasing our understanding of women’s sexuality at midlife and beyond.Menopause. 2011; 18: 1149-1151
- The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.Climacteric. 2012; 15: 267-274
- Recommendations for the management of postmenopausal vaginal atrophy.Climacteric. 2010; 13 (Epub 2010 Sep 30): 509-522
- Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative US probability sample of men and women 57–85 years of age.J Sex Med. 2008; 5: 2300-2311
- Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study.Eur Urol. 2004; 45: 642-648
- The relative effect of hormones and relationship factors on sexual function of women through the natural menopausal transition.Fertil Steril. 2005; 84: 174-180
- Hormones and sexuality during transition to menopause.Obstet Gynecol. 2007; 109: 831-840
- Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status.J Sex Med. 2008; 5: 1214-1222
- A higher sense of purpose in life is associated with sexual enjoyment in midlife women.Menopause. 2011; 18: 39-844
- Association of lifestyle and relationship factors with sexual functioning of women during midlife.J Sex Med. 2009; 6: 1358-1368
- Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause.Maturitas. 2010; 67 (Epub 2010 Jun 16): 78-83
- A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitude and Behaviors.Arch Sex Behav. 2006; 2 (Epub 2006 Apr 26): 145-161
- Assessment of sexuality among middle-aged women using the Female Sexual Function Index.Climacteric. 2009; 12: 213-221
- Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index.Menopause. 2009; 16: 1139-1148
- Women’s perception of sexuality around the menopause: outcomes of a European telephone survey.Eur J Obstet Gynecol Reprod Biol. 2008; 137 (Epub 2007 Jan 4): 10-16
- Prevalence and evaluation of sexual health problems— HSDD in Europe.J Sex Med. 2007; 4: 211-219
- Patterns and predictors of sexual activity among women in the hormone therapy trials of the Women’s Health Initiative.Menopause. 2011; 18: 1160-1171
- Sexual function in chronic illness.J Sex Med. 2010; 7: 374-388
- Female sexual dysfunction: therapeutic options and experimental challenges.Cardiovasc Hematol Agents Med Chem. 2009; 7: 260-269
- Diabetes mellitus and sexual function in middle-aged and older women.Obstet Gynecol. 2012; 120: 331-340
- Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.J Clin Psychopharmacol. 2009; 29: 259-266
- Correlates of sexual satisfaction among sexually active postmenopausal women in the Women’s Health Initiative—observational study.J Gen Intern Med. 2008; 23 (Epub 2008 Oct 7): 2000-2009
- Risk of hypoactive sexual desire disorder and associated factors in a cohort of oophorectomized women.Climacteric. 2009; 12: 525-532
- Surgical menopause: effects on psychological well-being and sexuality.Menopause. 2007; 14: 586-591
- Sexual activity and satisfaction in healthy community-dwelling older women.Am J Med. 2012; 125: 37-43
- Female sexual dysfunction [practice bulletin].Ob-Gyn. 2011; 119: 996-1003
- Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder.J Clin Psychiatry. 2010; 71: 821-822
- Pathways of sexual desire.J Sex Med. 2009; 6: 1506-1533
- Physiology of women’s sexual function; basic knowledge and new findings.J Sex Med. 2010; 8: 2637-2660
- International Statistical Classification of Diseases and Related Health Problems, 10th rev.World Health Organization, Geneva1992
- Diagnostic and Statistical Manual of Mental Disorders, 5th ed, text rev.American Psychiatric Association, Washington, DC2013
- Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications.J Urol. 2000; 163: 888-893
- Is it time to move on from “hypoactive sexual desire disorder”?.Menopause. 2010; 17: 1097-1098
- Androgen levels in adult females: changes with age, menopause, and oophorectomy.J Clin Endocrinol Metab. 2005; 90: 3847-3953
- Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: Role of the ovary?.Menopause. 2011; 18: 30-43
- The role of androgen therapy.Best Pract Res Clin Endocrinol Metab. 2003; 17: 165-175
- Role of androgens in women’s sexual dysfunction.Menopause. 2010; 17: 962-971
- 2012 Hormone Therapy Position Statement of the North American Menopause Society.Menopause. 2012; 19: 257-271
- The use of estrogen therapy in women’s sexual function.J Sex Med. 2009; 6: 603-616
- Therapeutic options for postmenopausal female sexual dysfunction.Climacteric. 2010; 13: 103-120
- Efficacy and tolerability of local estrogen therapy for urogenital atrophy.Menopause. 2010; 17: 194-203
- Endogenous estrogen levels affect sexual function in elderly post-menopausal women.Maturitas. 2004; 49: 124-133
- Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.Menopause. 2012; 19: 109-117
- Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.Menopause. 2008; 15: 661-667
- Sexual dysfunction: treat or refer.Obstet Gynecol. 2005; 106: 834-839
- Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.J Sex Med. 2011; 8: 2831-2840
- A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.J Clin Psychopharmacol. 2006; 26: 482-488
- Sexuality and sexual disorders.Clinical Updates in Women’s Health Care. American College of Obstetricians and Gynecologists, Washington, DC2014: 50-53
- The Hypoactive Sexual Desire Disorder Registry to characterize the natural history and outcomes of women with hypoactive sexual desire disorder.Menopause. 2012; 19: 379-381
- Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.Climacteric. 2011; 14: 302-320
- Local oestrogen for vaginal atrophy in postmenopausal women (review).Cochrane Database Syst Rev. 2006; 4: CD001500
- The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.Menopause. 2007; 14: 355-369
- A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.Menopause. 2009; 16: 247-256
- The role of testosterone in women.Climacteric. 2009; 12: 185-187
- Testosterone for peri- and postmenopausal women.Cochrane Database Syst Rev. 2005; 4: CD004509
- Effects of aromatase inhibitors on sexual function and well-being in postmenopausal women treated with testosterone; a randomized, placebo-controlled trial.Menopause. 2006; 13: 37-45
- Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.N Engl J Med. 2000; 343: 682-688
- Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.Obstet Gynecol. 2005; 105: 944-952
- Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.Arch Intern Med. 2005; 165: 1582-1589
- Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.J Clin Endocrinol Metab. 2005; 90 (Epub 2005 Jul 12): 5226-5233
- Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized placebo-controlled trial.Menopause. 2006; 13: 387-396
- Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study.Menopause. 2006; 13: 770-779
- Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.J Sex Med. 2007; 4: 1001-1008
- Testosterone for low libido in menopausal women not taking estrogen.N Engl J Med. 2008; 359: 2005-2017
- Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.Climacteric. 2010; 13: 121-131
- A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.Climacteric. 2007; 10: 335-343
- Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido: effects on sexuality and psychological general well-being.Maturitas. 2006; 53: 11-18
- Postmenopausal hormone therapy: an Endocrine Society scientific statement.J Clin Endocrinol Metab. 2010; 95: S1-S66
- The safety of testosterone therapy in women.J Obstet Gynaecol Can. 2012; 34: 859-865
- Efficacy and safety of testosterone in HSDD.J Sex Med. 2012; 9: 1134-1148
- Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.Gynecol Endocrinol. 2011; 27: 39-48
- Study of adverse outcomes in women using testosterone therapy.Maturitas. 2009; 62 (Epub 2008 Dec 24): 76-80
- Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.J Sex Med. 2008; 5: 646-656
- DHEA for postmenopausal women: a review of the evidence.Maturitas. 2010; 66: 172-179
- Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.Menopause. 2009; 16: 923-931
- 2013 position statement of The North Amerian Menopause Society.Menopause. 2013; 20: 888-902
- Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.J Sex Marital Ther. 2012; 38: 41-62
- Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.J Sex Marital Ther. 2001; 27: 411-420
- Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.J Womens Health Gend Based Med. 2002; 11: 367-377
- A new non-pharmacological vacuum therapy for female sexual dysfunction.J Sex Marital Ther. 2001; 27: 435-441
- Sexual psychophysiology and effects of sildenafil citrate in estrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trail.BJOG. 2003; 110: 1014-1024
- Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.JAMA. 2008; 300: 395-404
- Sildenafil effects on sexual and cardiovascular reponses in women with spinal cord injury.Urology. 2000; 55: 812-815
- Associations of depression with the transition to menopause.Menopause. 2010; 17: 823-827
- Prevalence of depression and its correlates in older adults.Am J Epidemiol. 1983; 117: 173-185
- Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.Prim Care Companion J Clin Psychiatry. 2010; 12 (PCC.08r00747)
- Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and Cycles.Arch Gen Psychiatry. 2003; 60: 29-36
- Antidepressants and sexual dysfunction.Acta Psychiatr Scand. 2006; 114: 385-397
- Distressing sexual problems in United States women revisited: prevalence after accounting for depression.J Clin Psychiatry. 2009; 70: 1698-1706
- Management strategies in SSRI-associated sexual dysfunction in women at midlife.Climacteric. 2012; 15: 306-316
- A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.J Clin Psychiatry. 2004; 65: 62-67
- The impact of premature ovarian insufficiency on sexual function.Menopause. 2011; 18: 246-247
- Sexual function in young women with spontaneous 46XX primary ovarian insufficiency.Fertil Steril. 2008; 90: 1805-1811
- Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure.Menopause. 2008; 15: 23-31
- Sexual function of women with premature ovarian failure.Menopause. 2011; 18: 262-266
- Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.Breast Cancer Res Treat. 2002; 76: 27-36
- Management of gynecologic issues in women with breast cancer. Practice Bulletin No. 126, March 2012.Obstet Gynecol. 2012; 119: 666-682
- Sexuality after breast cancer: a review.Maturitas. 2010; 66: 397-407
- Sexual outcomes of aromatase inhibitor therapy in women with breast cancer: time for intervention.Menopause. 2013; 20: 128-129
- Sexual function after breast cancer.J Sex Med. 2011; 8: 294-302
- Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.Menopause. 2013; 20: 162-168
- Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.Ann Oncol. 2006; 17 (Epub 2006 Jan 27): 584-587
- Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.Climacteric. 2011; 14: 339-344
- Sexuality in adult cancer survivors: challenges and intervention.J Clin Oncol. 2012; 30: 3712-3719
- Recommendations for the clinical evaluation of men and women with sexual dysfunction.J Sex Med. 2010; 7: 337-348
Article Info
Identification
Copyright
© 2014 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.
